A recent meta-analysis comparing two anti-VEGF therapies—brolucizumab and aflibercept—for the treatm...

A multinational study by the LHON Study Group has reported sustained visual improvements and a favor...

A recent study published in Clinical Ophthalmology demonstrated that a bio-interventional cyclodialy...

NurExone Biologic has initiated a preclinical study to investigate the potential of its exosome-base...

Valo Health has announced the results of its Phase 2 SPEC¬TRA study evaluating OPL-0401 in patients ...

Exonate Ltd. announced promising Phase Ib/IIa clinical trial results for its leading drug candidate,...

Regeneron, a global biotechnology leader, has acquired Oxular, a UK-based clinical-stage company spe...

Ocugen has announced that the second phase of the OCU410 ArMaDa clinical trial will continue followi...

Neurolens announced the findings of a research study aimed at evaluating the efficacy of its prescri...

Telios Pharma, Inc. announced promising topline results from its Phase 2 study of TL-925, a pioneeri...